vimarsana.com

Page 7 - Automated Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemostemix Inc : Hemostemix to Combine ACP-01 with Dr James Shapiro s Islet Cells to Treat Type 1 Diabetes

Calgary, Alberta (Newsfile Corp. - January 11, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it has signed a contract with Dr.

Thomas smeenkJames shapiroFraser hendersonRoyal society of canadaUniversity of albertaRoyal college of surgeons englandRegulation service providerDepartment of surgeryWorld economic forum technology pioneer awardHemostemix incCanada research councilAlberta newsfile corpVenture exchangeEngland journalHunterian medalRoyal college

Hemostemix Inc : Hemostemix Announces Soft Lock of Database as Source Document Verification Completed

Calgary, Alberta (Newsfile Corp. - December 9, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB :HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the source document verification process

Thomas smeenkWorld economic forum technology pioneer awardHemostemix incRegulation service providerAlberta newsfile corpVenture exchangeHealth sciencesAspire health sciencesIschemic cardiomyopathyDilated cardiomyopathyStem cell treatmentRegulating stem cellsVitro techniquesStem cellsNeural lineageAutomated cell

Hemostemix Inc : Hemostemix Confirms OTCQB Listing

Calgary, Alberta (Newsfile Corp. - October 28, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it is now up-listed to trade on the

Blue skyThomas smeenkRegulation service providerFrankfurt stock exchangeWorld economic forum technology pioneer awardHemostemix incBlue sky monitoring servicesAlberta newsfile corpVenture exchangeSky monitoring servicesIschemic cardiomyopathyDilated cardiomyopathyStem cell treatmentRegulating stem cellsVitro techniquesStem cells

Hemostemix Inc : Hemostemix Announces Dr Fraser C Henderson Sr , MD, as Chief Medical Officer

Calgary, Alberta (Newsfile Corp. - October 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Fraser C. Henderson

United statesQueen squareSouth australiaNational naval medical centerGeorgetown universityDistrict of columbiaCity ofUnited kingdomThomas smeenkFraserc hendersonAlan crockardPhanor perotPierre leimgruberFraser hendersonOncology divisionChiari syringomyelia foundation greater metropolitan washington chapter

Hemostemix Inc : Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain

Calgary, Alberta (Newsfile Corp. - October 4, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the second in its series of video interviews with

United statesThomas smeenkWorld economic forum technology pioneer awardHemostemix incBristol myers squibbRegulation service providerAlberta newsfile corpVenture exchangeMinnesota heart instituteKit aromDilated cardiomyopathyIschemic cardiomyopathyStem cell treatmentRegulating stem cellsVitro techniquesStem cells

vimarsana © 2020. All Rights Reserved.